PRF Technologies (PRFX) Stock Price

PRF Technologies Price

NASDAQ·CLOSED
0.98
+0.00 (+0.00 %)
Market closed

Analysts set a median price target of 2.04 USD, implying 108.9% above the current price. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus. The stock trades about 14% above its 52-week low.

PRF Technologies stock price

Access this data via the Eulerpool API

PRF Technologies business model & stock analysis

Frequently asked questions about PRF Technologies

Analysts currently set an average price target of 2.04 USD for the PRF Technologies stock (median: 2.04 USD), implying +108.9 % versus the latest price. The consensus is based on 7 analyst ratings.

6 analysts currently rate the PRF Technologies stock: 0 recommend buying, 3 holding and 3 selling.

Converted at the current exchange rate, the PRF Technologies share trades at 0.86 EUR (0.98 USD).

The PRF Technologies share (PRFX) is listed on 1 stock exchanges, including: NASDAQ (PRFX).

No history available for PRF Technologies.

The revenue cannot currently be calculated for PRF Technologies.

The expected profit of PRF Technologies is -28.07 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of PRF Technologies is currently -0.00. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the PRF Technologies stock.

The P/S cannot be calculated for PRF Technologies currently.

The Eulerpool Quality Score for PRF Technologies is 2/10.

The ISIN of PRF Technologies is IL0011651580. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of PRF Technologies is PRFX. The ticker symbol is used to trade PRF Technologies shares on the stock exchange.

PRF Technologies paid dividends every year for the past 0 years.

PRF Technologies is assigned to the 'Health' sector.

The dividends of PRF Technologies are distributed in USD.

Fair ValueTerminal
0.83 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Israel
Currency
USD
Initial public offering
Sep 1, 2020
ISIN
IL0011651580
Cusip
M77798128
Market capitalization
52-Week Range
0.86–7.40USD
Revenue growth (10Y) > 5%
Revenue growth (3Y) > 5 %
EBIT growth (10Y) > 5%
EBIT growth (3Y) > 5 %
Net debt < 4x EBIT
Profitable since 10Y+
EBIT Drawdown (10Y) < 50%
Return on Equity (ROE) > 15%
ROCE > 15%
Return Expectation > 10%
PEG
—
P/E ratio
P/Ee 2025
-0.00
P/Ee 2026
-0.00
P/S
P/Se
—
EV/EBIT
0.24
P/B Ratio
0.42
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-799.78 %
Gross Margin
—
EBIT Margin
—
Net Margin
—
EPS (Earnings Per Share)
-160.84 USD
Net Debt / EBIT
0.29
Debt/Equity
0.00
Last updated Sep 27, 2026, 9:09 AM

PRF Technologies Peer Group

PRF Technologies Ticker

NASDAQ · PRFX

PRF Technologies FIGI

PRFX:US · BBG00VT0S8T0PRFX:UA · BBG00VT0S8V7PRFX:UC · BBG00VT0S8W6PRFX:UN · BBG00VT0S8Y4PRFX:UP · BBG00VT0S8Z3PRFX:UB · BBG00VT0S918PRFX:UM · BBG00VT0S936PRFX:UX · BBG00VT0S945PRFX:UR · BBG00VT0S954PRFX:UD · BBG00VT0S990PRFX:UF · BBG00VT0S9D5PRFX:VY · BBG00VT0S9F3